Peach Life Science Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Peach Life Science Co., Ltd. - overview
Established
2022
Location
Seoul, -, South Korea
Primary Industry
Medical Devices & Equipment
About
Based in Seoul, South Korea, founded in 2022, Peach Life Science Co. , Ltd. operates as a company that focuses on the development of electronic medical devices. In October 2025, Peach Life Science raised seed funding from Innocuve and Yonsei Biohealth Technology Holdings.
As of 2025, the company is led by its CEO Park Jae-jun. Peach Life Science specializing in developing next-generation electronic medicines. The company's solutions target neurological conditions such as ADHD. The firm leverages proprietary circuit and electrode technologies to develop safe, user-friendly bioelectronic systems.
Current Investors
Innocuve, Yonsei Biohealth Technology Holdings
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Pharmaceuticals
Verticals
HealthTech, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.